Takeda announced that Costa Saroukos, chief financial officer, has decided to leave Takeda to return to his home-country of Australia to be closer to family. Saroukos will step down as CFO, effective April 1, 2024 and will remain with the company as a board director until June 28, 2024. Milano Furuta, president of Takeda’s Japan…
Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager for India operations. The appointment is effective as of March 1, 2022. In her new role, Serina will lead the company’s business in India, ensuring patient access to the company’s highly innovative medicines, a statement said.…
Takeda Pharmaceutical Company Limited (Takeda) announced the exercise of its option to acquire Adaptate Biotherapeutics (Adaptate), a UK company focused on developing antibody-based therapeutics for the modulation of variable delta 1 (Vδ1) gamma delta (γδ) T cells. Through the acquisition, Takeda will obtain Adaptate’s antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery…
Takeda Pharmaceutical Company Limited has announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy. “We’re committed to developing cell therapies that will have an impact on large segments of patients by focusing on off-the-shelf, allogeneic cell therapies…
Amwell, a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care, announced that it has closed its Series C financing round, adding $194 million in funding across two tranches. Many early investors and strategic partners participated in…